• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磁共振成像诊断肝硬化小肝癌的延迟低信号和延迟强化环的价值。

Value of delayed hypointensity and delayed enhancing rim in magnetic resonance imaging diagnosis of small hepatocellular carcinoma in the cirrhotic liver.

机构信息

Department of Radiology, University of Michigan, Ann Arbor, Michigan 48109, USA.

出版信息

J Magn Reson Imaging. 2010 Aug;32(2):360-6. doi: 10.1002/jmri.22271.

DOI:10.1002/jmri.22271
PMID:20677263
Abstract

PURPOSE

To determine the diagnostic utility of delayed hypointensity and delayed enhancing rim on magnetic resonance imaging (MRI) as indicators of hepatocellular carcinoma (HCC) in arterially enhancing nodules < or =5 cm in the cirrhotic liver and determine the features that best predict HCC.

MATERIALS AND METHODS

Gadolinium-enhanced MRI studies performed from January 2001 to December 2004 in patients with cirrhosis were evaluated for arterially enhancing nodules measuring < or =5 cm. Verification was via explant correlation, biopsy, or imaging follow-up. Sensitivity and specificity of diagnostic features of HCC were calculated. Features predictive of HCC were determined using the Generalized Estimating Equation approach.

RESULTS

In all, 116 arterially enhancing nodules were identified in 80 patients (<2 cm: n = 79, 2-5 cm n = 37). Sensitivity and specificity of delayed hypointensity for HCC measuring < or =5 cm, 2-5 cm, and <2 cm were 0.54 (40 of 74) and 0.86 (36 of 42); 0.72 (23 of 32) and 0.80 (4 of 5); and 0.41 (17 of 42) and 0.87 (32 of 37). For the delayed enhancing rim sensitivity and specificity were 0.64 (47 of 74) and 0.86 (36 of 42); 0.75 (24 of 32) and 1.0 (5 of 5); and 0.55 (23 of 42) and 0.83 (31 of 37), respectively. Lesion size (> or =2 cm) and delayed enhancing rim, as main features and their interaction, were the most significant predictors of HCC.

CONCLUSION

Delayed hypointensity and enhancing rim improve the specificity of diagnosis of HCC of all sizes but are seen less frequently in small (<2 cm) HCC. Nodule size (> or =2 cm) and delayed enhancing rim are the strongest predictors of HCC.

摘要

目的

确定磁共振成像(MRI)中延迟低信号和延迟增强边缘作为肝硬化肝脏中 <或= 5cm 动脉增强结节的肝细胞癌(HCC)指标的诊断效用,并确定最佳预测 HCC 的特征。

材料与方法

对 2001 年 1 月至 2004 年 12 月进行的 MRI 增强检查进行评估,纳入肝硬化患者的动脉增强结节直径 <或= 5cm。通过切除物相关性、活检或影像学随访来进行验证。计算 HCC 诊断特征的敏感性和特异性。使用广义估计方程方法确定 HCC 的预测特征。

结果

共发现 80 例患者的 116 个动脉增强结节(<2cm:n = 79,2-5cm:n = 37)。<或= 5cm、2-5cm 和 <2cm 的 HCC 患者延迟低信号的敏感性和特异性分别为 0.54(74 例中的 40 例)和 0.86(42 例中的 36 例)、0.72(32 例中的 23 例)和 0.80(5 例中的 5 例)和 0.41(42 例中的 17 例)和 0.87(37 例中的 32 例)。对于延迟增强边缘,敏感性和特异性分别为 0.64(74 例中的 47 例)和 0.86(42 例中的 36 例)、0.75(32 例中的 24 例)和 1.0(5 例中的 5 例)和 0.55(42 例中的 23 例)和 0.83(37 例中的 31 例)。病变大小(>或=2cm)和延迟增强边缘,作为主要特征及其相互作用,是 HCC 的最强预测因素。

结论

延迟低信号和增强边缘提高了各种大小 HCC 的诊断特异性,但在较小 (<2cm) HCC 中则较少见。结节大小(>或=2cm)和延迟增强边缘是 HCC 的最强预测因素。

相似文献

1
Value of delayed hypointensity and delayed enhancing rim in magnetic resonance imaging diagnosis of small hepatocellular carcinoma in the cirrhotic liver.磁共振成像诊断肝硬化小肝癌的延迟低信号和延迟强化环的价值。
J Magn Reson Imaging. 2010 Aug;32(2):360-6. doi: 10.1002/jmri.22271.
2
Small hypervascular hepatocellular carcinoma: limited value of portal and delayed phases on dynamic magnetic resonance imaging.小的富血管性肝细胞癌:动态磁共振成像中门静脉期和延迟期的价值有限
Acta Radiol. 2008 Sep;49(7):735-43. doi: 10.1080/02841850802120045.
3
Arterial enhancing-only nodules less than 2 cm in diameter in patients with liver cirrhosis: predictors of hepatocellular carcinoma diagnosis on gadobenate dimeglumine-enhanced MR imaging.直径小于 2 厘米的肝硬化患者动脉期增强仅有结节:钆贝葡胺增强磁共振成像诊断肝细胞癌的预测因素。
J Magn Reson Imaging. 2013 Apr;37(4):892-902. doi: 10.1002/jmri.23873. Epub 2012 Oct 23.
4
Serial MR imaging of small arterially-enhancing liver lesions in patients with chronic liver disease.慢性肝病患者肝脏小动脉强化病变的系列磁共振成像
J Med Assoc Thai. 2009 Apr;92(4):548-55.
5
Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.扩散加权磁共振成像在肝硬化肝脏中肝细胞癌和发育异常结节特征描述中的作用
J Comput Assist Tomogr. 2010 Jul;34(4):506-12. doi: 10.1097/RCT.0b013e3181da3671.
6
Transplantation for hepatocellular carcinoma and cirrhosis: sensitivity of magnetic resonance imaging.肝细胞癌和肝硬化的移植:磁共振成像的敏感性
Liver Transpl. 2002 Dec;8(12):1156-64. doi: 10.1053/jlts.2002.35670.
7
Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.超顺磁性氧化铁增强 MRI 成像在肝硬化肝脏肝细胞癌无创成像诊断中的附加价值。
Invest Radiol. 2009 Dec;44(12):800-7. doi: 10.1097/RLI.0b013e3181bc271d.
8
Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.钆塞酸增强磁共振成像在鉴别 < 或 = 2cm 直径的小肝癌和动脉期增强假性病灶中的应用:特别强调肝胆期成像。
Invest Radiol. 2010 Feb;45(2):96-103. doi: 10.1097/RLI.0b013e3181c5faf7.
9
The risk of hepatocellular carcinoma in cirrhotic patients with small liver nodules on MRI.磁共振成像显示肝脏有小结节的肝硬化患者发生肝细胞癌的风险
Am J Gastroenterol. 2006 Mar;101(3):533-40. doi: 10.1111/j.1572-0241.2006.00450.x.
10
The value of gadobenate dimeglumine-enhanced delayed phase MR imaging for characterization of hepatocellular nodules in the cirrhotic liver.钆布醇增强延迟期磁共振成像在肝硬化肝脏肝细胞结节特征性诊断中的价值
Invest Radiol. 2008 Mar;43(3):202-10. doi: 10.1097/RLI.0b013e31815d6929.

引用本文的文献

1
Development and validation of a CT-based nomogram for accurate hepatocellular carcinoma detection in high risk patients.基于CT的列线图在高危患者中准确检测肝细胞癌的开发与验证
Front Oncol. 2024 Aug 6;14:1374373. doi: 10.3389/fonc.2024.1374373. eCollection 2024.
2
Improved diagnosis of histological capsule in hepatocallular carcinoma by using nonenhancing capsule appearance in addition to enhancing capsule appearance in gadoxetic acid-enhanced MRI.在钆塞酸增强 MRI 中,除了增强的包膜表现外,利用非增强的包膜表现可改善肝细胞癌的组织学包膜诊断。
Sci Rep. 2023 Apr 14;13(1):6113. doi: 10.1038/s41598-023-33048-8.
3
The role of enhancing capsule and modified capsule appearances in LI-RADS for diagnosing HCC ≤ 3.0 cm on gadoxetate disodium-enhanced MRI.
在钆塞酸二钠增强磁共振成像中,强化包膜和改良包膜表现对肝脏影像报告和数据系统(LI-RADS)诊断直径≤3.0 cm肝细胞癌的作用。
Eur Radiol. 2023 Aug;33(8):5801-5811. doi: 10.1007/s00330-023-09487-2. Epub 2023 Mar 10.
4
Clinical Significance of Liver MR Imaging.肝脏磁共振成像的临床意义。
Magn Reson Med Sci. 2023 Apr 1;22(2):157-175. doi: 10.2463/mrms.rev.2022-0100. Epub 2023 Feb 1.
5
Usefulness of F-FDG PET/CT and Multiphase CT in the Differential Diagnosis of Hepatocellular Carcinoma and Combined Hepatocellular Carcinoma-Cholangiocarcinoma.F-FDG PET/CT与多期CT在肝细胞癌及肝细胞癌-胆管癌合并症鉴别诊断中的应用价值
Taehan Yongsang Uihakhoe Chi. 2020 Nov;81(6):1424-1435. doi: 10.3348/jksr.2019.0154. Epub 2020 Nov 30.
6
Current Imaging Diagnosis of Hepatocellular Carcinoma.肝细胞癌的当前影像诊断
Cancers (Basel). 2022 Aug 18;14(16):3997. doi: 10.3390/cancers14163997.
7
CT/MRI LI-RADS v2018 vs. CEUS LI-RADS v2017-Can Things Be Put Together?CT/MRI版LI-RADS v2018与CEUS版LI-RADS v2017——能否整合?
Biology (Basel). 2021 May 6;10(5):412. doi: 10.3390/biology10050412.
8
Evaluation of LI-RADS 3 category by magnetic resonance in US-detected nodules ≤ 2 cm in cirrhotic patients.MRI 检测肝硬化患者直径≤2cm 结节时对 LI-RADS 3 类的评估。
Eur Radiol. 2021 Jul;31(7):4794-4803. doi: 10.1007/s00330-020-07457-6. Epub 2021 Jan 6.
9
Atypical Appearance of Hepatocellular Carcinoma and Its Mimickers: How to Solve Challenging Cases Using Gadoxetic Acid-Enhanced Liver Magnetic Resonance Imaging.肝细胞癌及其类似物的不典型表现:如何使用钆塞酸增强肝脏磁共振成像解决具有挑战性的病例。
Korean J Radiol. 2019 Jul;20(7):1019-1041. doi: 10.3348/kjr.2018.0636.
10
Magnetic resonance imaging features predictive of an incomplete response to transarterial chemoembolization in patients with hepatocellular carcinoma: A STROBE-compliant study.预测肝细胞癌患者经动脉化疗栓塞不完全反应的磁共振成像特征:一项符合STROBE标准的研究。
Medicine (Baltimore). 2019 May;98(19):e15592. doi: 10.1097/MD.0000000000015592.